CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade DiaMedica Therapeutics Inc. - DMAC CFD

6.4996
1.52%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0508
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023512 %
Charges from full value of position ($-4.47)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023512%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00129 %
Charges from full value of position ($0.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00129%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 6.5996
Open 6.4996
1-Year Change 125.44%
Day's Range 6.4396 - 6.5496
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 21, 2025 6.4996 0.0100 0.15% 6.4896 6.5696 6.4396
Feb 20, 2025 6.5996 -0.0800 -1.20% 6.6796 6.7296 6.5396
Feb 19, 2025 6.6096 0.6200 10.35% 5.9896 6.7796 5.6396
Feb 18, 2025 6.1496 -0.0100 -0.16% 6.1596 6.2196 6.0096
Feb 14, 2025 6.2596 0.1800 2.96% 6.0796 6.3396 5.9596
Feb 13, 2025 6.1996 -0.0800 -1.27% 6.2796 6.2796 6.0796
Feb 12, 2025 6.2696 0.0300 0.48% 6.2396 6.3096 6.1896
Feb 11, 2025 6.2396 -0.0500 -0.79% 6.2896 6.2996 6.0096
Feb 10, 2025 6.3696 0.1200 1.92% 6.2496 6.4296 6.0496
Feb 7, 2025 6.1896 0.2300 3.86% 5.9596 6.2196 5.9596
Feb 6, 2025 6.1496 0.1300 2.16% 6.0196 6.3596 5.9896
Feb 5, 2025 6.0196 0.1600 2.73% 5.8596 6.1196 5.8596
Feb 4, 2025 5.9396 0.1000 1.71% 5.8396 6.0096 5.8396
Feb 3, 2025 5.8096 0.2500 4.50% 5.5596 5.8896 5.5596
Jan 31, 2025 5.6596 -0.1300 -2.25% 5.7896 5.9196 5.4996
Jan 30, 2025 5.8396 0.2800 5.04% 5.5596 5.9196 5.5396
Jan 29, 2025 5.8796 0.1200 2.08% 5.7596 5.9596 5.7596
Jan 28, 2025 5.9396 0.1700 2.95% 5.7696 6.0796 5.3796
Jan 27, 2025 6.0096 -0.1300 -2.12% 6.1396 6.2996 6.0096
Jan 24, 2025 6.2696 0.3200 5.38% 5.9496 6.3596 5.9496

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

DiaMedica Therapeutics Inc. Company profile

About DiaMedica Therapeutics Inc

DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for neurological and kidney diseases, such as acute ischemic stroke (AIS) and chronic kidney disease (CKD). The Company's lead product DM199 mimics the behavior of naturally occurring human KLK1 proteins to preserve and restore circulation to stroke-damaged tissue and improve overall kidney function. KLK1 is a serine protease, or protein, produced primarily in the kidneys, pancreas and salivary glands. DM199 therapy has the potential to improve circulation and overall function of critical systems, as well as reduce inflammation and oxidative stress. The Company also has other product pipelines for IgA Nephropathy and African Americans with CKD.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, DiaMedica Therapeutics Inc revenues was not reported. Net loss increased 11% to $13.6M. Higher net loss reflects General and administrative - Balancing increase of 23% to $3.8M (expense), Research and development - Balancing increase of 7% to $8.3M (expense), Governmental assistance research incen decrease from $205K (income) to $0K.

Industry: Bio Therapeutic Drugs

301 Carlson Parkway
Suite 210
MINNEAPOLIS
MINNESOTA 55305
US

People also watch

BTC/USD

96,519.35 Price
+1.230% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

ETH/USD

2,691.23 Price
+1.950% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,936.56 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0149%
Short position overnight fee 0.0067%
Overnight fee time 22:00 (UTC)
Spread 0.30

XRP/USD

2.59 Price
+1.890% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01292

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading